Last updated on February 2018

Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRI

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Lymph Node Metastases | Malignant neoplasm of prostate
  • Age: - 100 Years
  • Gender: Male

Inclusion Criteria:

  • Male, aged 18 years Prostate cancer present (Gleason 7) and/or
  • PSA 15 and/or
  • Clinical or radiological Stage T3
  • Subject will be undergoing a pelvic lymph node dissection as part of the prostate cancer treatment.
  • Subject is willing to sign and date the study Informed Consent form
  • Signed, written informed consent

Exclusion Criteria:

  • Patients who cannot lie still for at least 30 minutes or comply with imaging
  • Subject has medical conditions that would limit study participation (per physician discretion)
  • Subject has hemochromatosis and liver disease
  • Subject has known allergy against Fe-products or dextranes
  • Subject is enrolled in one or more concurrent studies that would confound the study results of this study as determined by the study investigators
  • Previous treatment for prostate cancer (surgery, radiotherapy, chemotherapy, hormone androgen deprivation therapy)
  • Proven bony metastatic disease, visceral metastases or lymph node metastases above the level of the aortic bifurcation
  • Patients who will not get prostatectomy or pelvic lymph node dissection for any reason
  • Patient has absolute contra-indications to undergoing MRI scanning

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.